Hepatic flare after telbivudine withdrawal and efficacy of postpartum antiviral therapy for pregnancies with chronic hepatitis B virus

201646 citationsJournal Articlehybrid Open Access

Authors

Jinfeng Liu · First Affiliated Hospital of Xi'an Jiaotong University

Jing Wang · First Affiliated Hospital of Xi'an Jiaotong University

Dongfang Jin · First Hospital of Xi'an

Caijing Qi · First Affiliated Hospital of Xi'an Jiaotong University

Taotao Yan · First Affiliated Hospital of Xi'an Jiaotong University

Furong Cao · First Affiliated Hospital of Xi'an Jiaotong University

Abstract

It is safe for the majority of women to withdraw telbivudine after delivery, whereas exciting serological response encourages extended antiviral therapy for mother with ALT elevation during pregnancy.

Topics & Keywords

Hepatitis B Virus Studies Hepatitis C virus research Liver Disease Diagnosis and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Gastroenterology and Hepatology

Volume 32, Issue 1, pp. 177-183

DOI: 10.1111/jgh.13436

Field-Weighted Citation Impact: 3.48